Skip to main content

Table 3 Evolution of pain during the study (100-mm VAS: 0 = no pain, 100 = maximum pain)

From: Intra-articular use of a medical device composed of hyaluronic acid and chondroitin sulfate (Structovial CS): effects on clinical, ultrasonographic and biological parameters

 

Visit 3 (one week)(n = 30)

Visit 4 (2 weeks)(n = 30)

Visit 5 (6 weeks)(n = 29)

Visit 6 (12 weeks)(n = 30)

Baseline, mm, mean ± SD

71.3 ± 14.71

71.3 ± 14.71

70.8 ± 14.73

71.3 ± 14.71

Post-baseline, mm, mean ± SD

48.0 ± 20.76

37.3 ± 21.87

31.3 ± 23.76

35.2 ± 24.59

Change, mm, mean ± SD

-23.3 ± 22.51

-34.0 ± 26.98

-39.5 ± 29.23

-36.1 ± 28.54

  1. mm = millimetres; n = number of patients; SD = standard deviation.